Search company, investor...

Compare Hydra Biosciences vs Selecta Biosciences

Customers evaluate the quality of Hydra Biosciences's products using the following success metrics.

Overview

Hydra Biosciences is 23 yrs old and is based in United States.

Hydra Biosciences is a biopharmaceutical company. It develops drugs to treat pain, inflammation, anxiety, and pulmonary diseases. Hydra Biosciences' proprietary platforms enable the company to identify and develop drug candidates that address significant unmet medical needs. The company was founded in 2001 and is based in Cambridge, Massachusetts.

Selecta Biosciences is based in United States

Selecta Biosciences is a biopharmaceutical company developing a new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. Selecta's Synthetic Vaccine Particle (SVP) platform creates a new paradigm in vaccine development, enabling completely new therapeutic applications while offering the potential of improved efficacy and safety profiles. Selecta's fully synthetic engineering of novel vaccines offers a number of compelling benefits, including flexible modular vaccine design and accelerated development timelines using robust manufacturing processes. Selecta's SVP platform technology is flexible to enable diverse vaccines and the company has created antigen-specific targeted Synthetic Vaccine Particles (tSVP) and antigen-specific targeted tolerogenic Synthetic Vaccine Particles (t2SVP).

Country

United States
United States

Demo Video

Demo not available because Hydra Biosciences has not claimed their profile.

Work for Hydra Biosciences? Show off your product.

Demo not available because Selecta Biosciences has not claimed their profile.

Work for Selecta Biosciences? Show off your product.

Leadership

Laurie Keating (Founder, Chief Executive Officer)

See all 5 people

Robert L Bratzler (Founder)

See all 5 people

Funding

Selecta Biosciences last raised $70M on 6/22/2016.

Total Raised

Investors

Eli Lilly and Company, Boehringer Ingelheim

See all 5 investors

Flagship Pioneering, Polaris Partners

See all 5 investors

Product

Benefits

Products

Customers

Known Partners

Why They Buy

Information not available because Hydra Biosciences has not claimed their profile.

Work for Hydra Biosciences? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Hydra Biosciences?

Claim your profile now.

Information not available because Selecta Biosciences has not claimed their profile.

Work for Selecta Biosciences? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Selecta Biosciences?

Claim your profile now.